Newsbytes
  • India
  • Business
  • World
  • Politics
  • Sports
  • Technology
  • Entertainment
  • Auto
  • Lifestyle
  • Inspirational
  • Career
  • Bengaluru
  • Delhi
  • Mumbai
  • Videos
  • Visual Stories
  • Reviews
  • Phone Reviews
  • Fitness Bands Reviews
  • Speakers Reviews
  • Find Cricket Statistics
Hindi
More
In the news
Heatwave
Char Dham Yatra
Gyanvapi Mosque
Newsbytes
Hindi
Newsbytes
User Placeholder

Hi,

Logout


India
Business
World
Politics
Sports
Technology
Entertainment
Auto
Lifestyle
Inspirational
Career
Bengaluru
Delhi
Mumbai
Videos
Visual Stories
Reviews
Phone Reviews
Fitness Bands Reviews
Speakers Reviews
Find Cricket Statistics

More Links
  • Videos

Download Android App

Follow us on
  • Facebook
  • Twitter
  • Linkedin
  • Youtube
 
Home / News / India News / COVAXIN supply to be increased as teens get COVID-19 vaccines
India

COVAXIN supply to be increased as teens get COVID-19 vaccines

COVAXIN supply to be increased as teens get COVID-19 vaccines
Written by Pratyush Deep Kotoky
Jan 03, 2022, 03:05 pm 2 min read
COVAXIN supply to be increased as teens get COVID-19 vaccines
Bharat Biotech aims to touch 100 crore vaccine doses in 2022 as India begins the inoculation of teenagers.

Pharmaceutical firm Bharat Biotech on Monday said it plans to increase the supply of its COVID-19 vaccine COVAXIN to up to eight crore doses a month, starting February. Currently, it is supplying five-six crore doses every month. The company aims to touch 100 crore vaccine doses in 2022 as India begins the inoculation of teenagers. Notably, COVAXIN is the only vaccine cleared for teenagers.

Context
Why does it matter?
  • India on Monday started the much-awaited COVID-19 vaccination for children aged 15 to 18 years.
  • Till 3 pm, nearly 34 lakh teenagers in that age group had registered on the government's Co-WIN portal to get vaccinated.
  • India would require around 15 crore doses for vaccinating this age group, which has a population of around 7.5 crore.
Details
'Bharat Biotech prepared to support vaccination of kids'

"Bharat Biotech is prepared and ready with its strategies to contribute to India's vaccination drive," a company spokesperson told CNN-News18. The company has augmented its production and is prepared to support the inoculation of teenagers, the spokesperson added. The company's Hyderabad and Ankleshwar plants will manufacture vaccines, while its Bengaluru and Pune plants will manufacture the drug substance or the active pharmaceutical ingredients (APIs).

Manufacture
'Productions on track and on target'

The spokesperson further said the manufacturing has been increased in a stepwise manner. This has been done in "specially designed Bio-Safety Level-3 production facilities in Hyderabad in Telangana, Malur in Karnataka, Ankleshwar in Gujarat, and Pune in Maharashtra." "The productions are on track and on target, with an aim to touch an annualized ~1.0 billion doses of COVAXIN," the spokesperson added.

COVAXIN
COVAXIN undergoes over 250 tests

While the production of COVAXIN has already gone up, the doses will only be ready for administration in February-March. It takes two to three months for manufactured jabs to reach supply lines. This is because the vaccine undergoes over 250 tests followed by tests in the government labs before supply. It also takes time to supply doses to vaccination centers.​

Information
No immediate rush expected at vaccination centers

India's total eligible population in the 15-18 year demographic stands at 7.5 crore, thus requiring 15 crore doses for complete vaccination. However, a source told CNN-News18 there would be no immediate rush at vaccination centers. "It has taken the adult vaccination program a full year to double vaccinate 50% of the eligible population. The vaccination program for children will also proceed on similar lines."

Share this timeline
Facebook
Whatsapp
Twitter
Linkedin
Pratyush Deep Kotoky
Pratyush Deep Kotoky
Twitter
Pratyush Deep Kotoky covers national and politics news at NewsBytes. His over three-year-long career involves reporting on sociopolitical issues across India, particularly the northeast region. His previous stints include 101Reporters, The Sunday Guardian, and Inshorts, and he has also written for Asia Times, Firstpost, and Newslaundry. He has a postgraduate degree in Journalism from the Indian Institute of Mass Communication, Delhi.
Latest
COVID-19
Bharat Biotech
COVAXIN
COVID-19 Vaccination
Related
Latest
Delhi: Heavy rains, thunderstorm cause power blackout; flight operations affected
Delhi: Heavy rains, thunderstorm cause power blackout; flight operations affected India
Samsung Galaxy A13 5G's European prices tipped; launch imminent
Samsung Galaxy A13 5G's European prices tipped; launch imminent Technology
Your guide to traveling to Dalhousie
Your guide to traveling to Dalhousie Lifestyle
Decoding Rohit Sharma's abysmal numbers in IPL 2022
Decoding Rohit Sharma's abysmal numbers in IPL 2022 Sports
2022 Benelli TRK 502 range arrives with more features
2022 Benelli TRK 502 range arrives with more features Auto
COVID-19
Woman, daughters found death in Delhi home; chilling note found
Woman, daughters found death in Delhi home; chilling note found India
Davos preps for World Economic Forum; Ukraine on agenda
Davos preps for World Economic Forum; Ukraine on agenda World
COVID-19: India reports 2,226 fresh cases, 65 more deaths
COVID-19: India reports 2,226 fresh cases, 65 more deaths India
Beijing: 13,000 COVID-19 negative people forced into quarantine
Beijing: 13,000 COVID-19 negative people forced into quarantine World
COVID-19: India reports 2,323 fresh cases, 25 more deaths
COVID-19: India reports 2,323 fresh cases, 25 more deaths India
More News
Bharat Biotech
Centre denies asking Bharat Biotech to address WHO's COVAXIN suspension
Centre denies asking Bharat Biotech to address WHO's COVAXIN suspension India
COVAXIN likely to get approval for children above 2yrs: Report
COVAXIN likely to get approval for children above 2yrs: Report India
Are Indian vaccines effective against Omicron? Here's what manufacturers say
Are Indian vaccines effective against Omicron? Here's what manufacturers say India
COVAXIN gets WHO approval for emergency use listing
COVAXIN gets WHO approval for emergency use listing India
Australia accepts COVAXIN as 'recognized' vaccine for incoming travelers
Australia accepts COVAXIN as 'recognized' vaccine for incoming travelers World
More News
COVAXIN
DCGI clears COVAXIN, Corbevax for children aged 6-12, 5-12 years
DCGI clears COVAXIN, Corbevax for children aged 6-12, 5-12 years India
COVID-19: China fighting worst outbreak, UK sets new high
COVID-19: China fighting worst outbreak, UK sets new high World
COVAXIN, Covishield will now be available in hospitals and clinics
COVAXIN, Covishield will now be available in hospitals and clinics India
PM Modi's address: COVID-19 vaccination for 15-18-year-olds, booster doses announced
PM Modi's address: COVID-19 vaccination for 15-18-year-olds, booster doses announced India
COVAXIN found 50% effective against COVID-19 in first real-world study
COVAXIN found 50% effective against COVID-19 in first real-world study India
More News
COVID-19 Vaccination
India defends wheat export ban at UN with COVID-19 barbs
India defends wheat export ban at UN with COVID-19 barbs World
COVID-19: India reports 2,364 fresh cases, 10 more deaths
COVID-19: India reports 2,364 fresh cases, 10 more deaths India
COVID-19: India reports 1,829 new cases, 33 more fatalities
COVID-19: India reports 1,829 new cases, 33 more fatalities India
COVID-19: India reports 1,569 new cases, 19 more deaths
COVID-19: India reports 1,569 new cases, 19 more deaths India
COVID-19: India logs 2,841 fresh cases, 9 more fatalities
COVID-19: India logs 2,841 fresh cases, 9 more fatalities India
More News
Related
5 lakh teens register to get COVID-19 vaccines from tomorrow
5 lakh teens register to get COVID-19 vaccines from tomorrow India
COVAXIN trial data for children aged 2-18 submitted to DCGI
COVAXIN trial data for children aged 2-18 submitted to DCGI India
COVID-19 vaccine trials for ages 3-12 soon: Zydus Cadila MD
COVID-19 vaccine trials for ages 3-12 soon: Zydus Cadila MD India
As vaccination pace remains slow, Centre may reduce private quota
As vaccination pace remains slow, Centre may reduce private quota India
Next News Article
Next News Article

Love India news?

Subscribe to stay updated.

India Thumbnail
India News Business News World News Politics News Sports News Technology News Entertainment News Auto News Lifestyle News Inspirational News
Career News Bengaluru News Delhi News Mumbai News Mukesh Ambani Indian Premier League (IPL) Karnataka Samsung Xiaomi West Bengal
Bihar Virat Kohli Rohit Sharma Haryana Narendra Modi Arvind Kejriwal Tamil Nadu Gujarat Yogi Adityanath YouTube
Instagram Hollywood News Uttar Pradesh Kerala Netflix Bollywood News Mamata Banerjee Maruti Suzuki Rahul Gandhi Elon Musk
Shah Rukh Khan Chelsea FC OPPO Akhilesh Yadav Indian Cricket Team Apple Manchester United Salman Khan Cryptocurrency OnePlus
Amitabh Bachchan ICC Women's World Cup Vivo India vs Sri Lanka
About Us Privacy Policy Terms & Conditions Contact Us Ethical Conduct Grievance Redressal News News Archive Topics Archive IPL 2022 Schedule IPL 2022 Points Table Find Cricket Statistics
Follow us on
Facebook Twitter Linkedin Youtube
All rights reserved © NewsBytes 2022